$NOTE
FiscalNote Holdings, Inc.

2021 Form 10-K Financial Statement

#000110465922045619 Filed on April 14, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020 Q3
Revenue $0.00
YoY Change
Cost Of Revenue $15.96M
YoY Change 66.91%
Gross Profit $66.95M
YoY Change 20.43%
Gross Profit Margin
Selling, General & Admin $5.940M
YoY Change 783.82%
% of Gross Profit 8.87%
Research & Development $24.02M
YoY Change 58.82%
% of Gross Profit 35.87%
Depreciation & Amortization $16.38M
YoY Change 42.32%
% of Gross Profit 24.46%
Operating Expenses $5.940M
YoY Change 783.82%
Operating Profit -$5.940M -$35.15K
YoY Change -110.81%
Interest Expense $2.213M
YoY Change -126.19%
% of Operating Profit
Other Income/Expense, Net $71.12K
YoY Change 131.74%
Pretax Income -$3.656M
YoY Change -59.78%
Income Tax -$1.259M
% Of Pretax Income
Net Earnings -$3.656M -$35.15K
YoY Change -59.78%
Net Earnings / Revenue
Basic Earnings Per Share -$19.80
Diluted Earnings Per Share -$167.1K
COMMON SHARES
Basic Shares Outstanding 15.50M
Diluted Shares Outstanding 15.50M

Balance Sheet

Concept 2021 2020 Q4 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $618.1K
YoY Change -98.6%
Cash & Equivalents $32.17M $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $462.5K
YoY Change -41.44%
Inventory
Prepaid Expenses $789.8K
Receivables $11.17M
Other Receivables $0.00
Total Short-Term Assets $1.081M $1.201M
YoY Change -10.06%
LONG-TERM ASSETS
Property, Plant & Equipment $7.509M
YoY Change -7.81%
Goodwill $120.7M
YoY Change
Intangibles
YoY Change
Long-Term Investments $175.1M
YoY Change 0.04%
Other Assets $2.709M
YoY Change 50.58%
Total Long-Term Assets $175.1M $175.0M
YoY Change 0.04%
TOTAL ASSETS
Total Short-Term Assets $1.081M $1.201M
Total Long-Term Assets $175.1M $175.0M
Total Assets $176.2M $176.2M
YoY Change -0.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.736M $4.291K
YoY Change 40371.79%
Accrued Expenses $2.942M $179.8K
YoY Change 1536.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due $13.57M
YoY Change 317.32%
Total Short-Term Liabilities $4.679M $359.7K
YoY Change 1200.72%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $25.81M
YoY Change -4.15%
Total Long-Term Liabilities $25.81M
YoY Change -4.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.679M $359.7K
Total Long-Term Liabilities $25.81M
Total Liabilities $30.49M $27.29M
YoY Change 11.73%
SHAREHOLDERS EQUITY
Retained Earnings -$26.06M
YoY Change
Common Stock $311.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $145.7M -$26.06M $0.00
YoY Change
Total Liabilities & Shareholders Equity $176.2M $176.2M
YoY Change -0.03%

Cashflow Statement

Concept 2021 2020 Q4 2020 Q3
OPERATING ACTIVITIES
Net Income -$3.656M -$35.15K
YoY Change -59.78%
Depreciation, Depletion And Amortization $16.38M
YoY Change 42.32%
Cash From Operating Activities -$1.030M $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$5.570M
YoY Change 1.46%
Acquisitions $43.63M
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.648M 0.000
YoY Change -99.06%
NET CHANGE
Cash From Operating Activities -1.030M 0.000
Cash From Investing Activities 0.000
Cash From Financing Activities 1.648M 0.000
Net Change In Cash 618.1K 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$1.030M $0.00
Capital Expenditures -$5.570M
Free Cash Flow $4.540M
YoY Change -17.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
NONE
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001823466
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dsac Threshold Business Days For Redemption Of Public Shares
ThresholdBusinessDaysForRedemptionOfPublicShares
P10D
CY2021 dei Document Type
DocumentType
10-K
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
175626
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4678689
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
359697
CY2021Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
6125000
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Entity File Number
EntityFileNumber
001-39672
CY2021 dei Entity Registrant Name
EntityRegistrantName
DUDDELL STREET ACQUISITION CORP.
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
6125000
CY2021 dei Security12g Title
Security12gTitle
None
CY2021Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
19687500
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4291
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2942445
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
179780
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
8/F Printing House
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
6 Duddell Street
CY2021 dei Entity Address Country
EntityAddressCountry
HK
CY2021 dei City Area Code
CityAreaCode
852
CY2021 dei Local Phone Number
LocalPhoneNumber
3468 6200
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Entity Shell Company
EntityShellCompany
true
CY2021Q2 dei Entity Public Float
EntityPublicFloat
130815000
CY2021 dei Auditor Firm
AuditorFirmId
688
CY2021 dei Auditor Name
AuditorName
Marcum LLP
CY2021 dei Auditor Location
AuditorLocation
Boston, MA
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
618138
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0
CY2020Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
411692
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
462473
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
789798
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1080611
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1201490
CY2021Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
175101805
CY2020Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
175030689
CY2021Q4 us-gaap Assets
Assets
176182416
CY2020Q4 us-gaap Assets
Assets
176232179
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1736244
CY2020Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
20805000
CY2021Q4 us-gaap Liabilities
Liabilities
30491189
CY2020Q4 us-gaap Liabilities
Liabilities
27289697
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29309210
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26057955
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-29308773
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-26057518
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176182416
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176232179
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5939873
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
672065
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4291
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2762665
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
109780
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1029722
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-5939873
us-gaap Operating Income Loss
OperatingIncomeLoss
-672065
dsac Offering Cost On Issuance Of Derivative Warrants
OfferingCostOnIssuanceOfDerivativeWarrants
469465
CY2021 us-gaap Interest Income Other
InterestIncomeOther
71118
us-gaap Interest Income Other
InterestIncomeOther
30688
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2212500
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
7980000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3656255
us-gaap Net Income Loss
NetIncomeLoss
-9090842
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-26057518
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
405000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3656255
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-29308773
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
0
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
550000
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
17541676
us-gaap Net Income Loss
NetIncomeLoss
-9090842
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-26057518
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3656255
us-gaap Net Income Loss
NetIncomeLoss
-9090842
CY2021 dsac General And Administrative Expenses Paid By Sponsor Under Note Payable
GeneralAndAdministrativeExpensesPaidBySponsorUnderNotePayable
88206
dsac General And Administrative Expenses Paid By Sponsor Under Note Payable
GeneralAndAdministrativeExpensesPaidBySponsorUnderNotePayable
62017
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
1260776
dsac Offering Cost On Issuance Of Derivative Warrants
OfferingCostOnIssuanceOfDerivativeWarrants
469465
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
71118
us-gaap Investment Income Interest
InvestmentIncomeInterest
30689
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2212500
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
7980000
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-327327
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
764798
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1731953
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0
dsac Cash Deposited In Trust Account
CashDepositedInTrustAccount
175000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-175000000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
175000000
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
323486
CY2021 us-gaap Repayments Of Debt
RepaymentsOfDebt
175626
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1500000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1647860
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
618138
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
dsac Prepaid Expenses Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares
PrepaidExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares
25000
dsac Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
70000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
175000000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
618138
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0
us-gaap Stock Issued1
StockIssued1
113610
dsac Offering Costs Included In Due To Related Party
OfferingCostsIncludedInDueToRelatedParty
327532
dsac Deferred Underwriting Commissions In Connection With The Initial Public Offering
DeferredUnderwritingCommissionsInConnectionWithTheInitialPublicOffering
6125000
dsac Gross Proceeds Received From Private Placement Held In Sponsors Bank Account
GrossProceedsReceivedFromPrivatePlacementHeldInSponsorsBankAccount
550000
dsac Offering Costs Paid By Sponsor Out Of Proceeds Received From Private Placement
OfferingCostsPaidBySponsorOutOfProceedsReceivedFromPrivatePlacement
3500000
CY2020Q4 dsac Gross Proceeds
GrossProceeds
175000000.0
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
10100000
CY2020Q4 dsac Deferred Underwriting Commissions
DeferredUnderwritingCommissions
6100000
CY2021 dsac Gross Proceeds
GrossProceeds
5500000
CY2021 dsac Maturity Years
MaturityYears
P185D
CY2021 dsac Minimum Percentage Of Trust Account Required For Business Combination
MinimumPercentageOfTrustAccountRequiredForBusinessCombination
0.80
CY2021Q4 dsac Redeem Shares
RedeemShares
10.00
CY2021Q4 us-gaap Assets Net
AssetsNet
5000001
CY2021Q4 us-gaap Restricted Investments Percent Of Net Assets
RestrictedInvestmentsPercentOfNetAssets
0.20
CY2021 dsac Threshold Period From Closing Of Public Offering Entity Is Obligated To Complete Business Combination
ThresholdPeriodFromClosingOfPublicOfferingEntityIsObligatedToCompleteBusinessCombination
P24M
CY2021 dsac Dissolution Expenses
DissolutionExpenses
100000
CY2021 dsac Trust Account Description
TrustAccountDescription
In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less up to $100,000 of interest to pay dissolution expenses).
CY2021 dsac Number Of Warrants Issued
NumberOfWarrantsIssued
1
CY2021 dsac Financial Advisors Fee
FinancialAdvisorsFee
5000000
CY2021Q4 us-gaap Cash
Cash
618000
CY2021Q4 dsac Working Capital Deficit
WorkingCapitalDeficit
3600000
CY2021Q4 dsac Working Capital Loans
WorkingCapitalLoans
0
CY2020Q4 us-gaap Due From Affiliate Noncurrent
DueFromAffiliateNoncurrent
2000000.0
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Use of Estimates</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of the consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Concentration of Credit Risk</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000, and investments held in the Trust Account. At December 31, 2021 and 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p>
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2020Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
1600000
CY2021 dsac Investments Maximum Maturity Term
InvestmentsMaximumMaturityTerm
P185D
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 dsac Net Amount Due From To Related Parties
NetAmountDueFromToRelatedParties
400000
CY2020Q4 dsac Deferred Underwriting Fees Payable Non Current
DeferredUnderwritingFeesPayableNonCurrent
6100000
CY2020Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
17500000
CY2020Q3 dsac Sponsor Agreed Description
SponsorAgreedDescription
The Sponsor agreed to surrender for no consideration 656,250 founder shares when the option to purchase additional units was not exercised by the underwriters.
CY2021 dsac Working Capital Loan
WorkingCapitalLoan
1500000
CY2021 dsac Price Per Share Warrants
PricePerShareWarrants
1.00
CY2021 dsac Maximum Threshold Period For Registration Statement To Become Effective After Business Combination
MaximumThresholdPeriodForRegistrationStatementToBecomeEffectiveAfterBusinessCombination
P60D
CY2021Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2021 dsac Threshold Trading Days For Calculating Market Value
ThresholdTradingDaysForCalculatingMarketValue
20
CY2021 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
9.20
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 dsac Maximum Number Of Demands For Registration Of Securities
MaximumNumberOfDemandsForRegistrationOfSecurities
3
CY2021 dsac Underwriting Discount Per Unit
UnderwritingDiscountPerUnit
0.20
CY2021Q4 dsac Deferred Underwriting Fees Amount Payable
DeferredUnderwritingFeesAmountPayable
3500000
CY2021 dsac Additional Unit Per Share
AdditionalUnitPerShare
0.35
CY2021Q4 dsac Aggregate Deferred Underwriting Commissions
AggregateDeferredUnderwritingCommissions
6100000
CY2021 dsac Proceeds From Issuance Of Temporary Equity
ProceedsFromIssuanceOfTemporaryEquity
175000000
CY2021 dsac Temporary Equity Proceeds Allocated To Warrants
TemporaryEquityProceedsAllocatedToWarrants
-7875000
CY2021 dsac Temporary Equity Issuance Costs
TemporaryEquityIssuanceCosts
-9666677
CY2021 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
17541677
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 dsac Warrants And Rights Outstanding Fractional Shares To Be Issued
WarrantsAndRightsOutstandingFractionalSharesToBeIssued
0
CY2021 dsac Warrants And Rights Outstanding Exercisable Term From Closing Of Business Combination
WarrantsAndRightsOutstandingExercisableTermFromClosingOfBusinessCombination
P30D
CY2021 dsac Warrants And Rights Outstanding Exercisable Term From Closing Of Initial Public Offering
WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering
P12M
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 dsac Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2020Q3 dsac Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2020Q4 dsac Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2021Q4 dsac Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2020Q3 dsac Threshold Conversion Ratio Of Stock
ThresholdConversionRatioOfStock
1
CY2021 dsac Newly Issued Price Percentage
NewlyIssuedPricePercentage
1.15
CY2021 dsac Threshold Period For Not To Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination
ThresholdPeriodForNotToTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination
P30D
CY2021 dsac Common Stock Trading Days On Which Fair Market Value Of Shares Is Reported
CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported
10
CY2021 dsac Maximum Thres Hold Period For Filing Registration Statement After Business Combination
MaximumThresHoldPeriodForFilingRegistrationStatementAfterBusinessCombination
P15D
CY2020Q3 dsac Threshold Conversion Ratio Of Stock
ThresholdConversionRatioOfStock
1
CY2020Q4 dsac Threshold Conversion Ratio Of Stock
ThresholdConversionRatioOfStock
1
CY2021 dsac Threshold Conversion Ratio Of Stock
ThresholdConversionRatioOfStock
1
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
3685000

Files In Submission

Name View Source Status
0001104659-22-045619-index-headers.html Edgar Link pending
0001104659-22-045619-index.html Edgar Link pending
0001104659-22-045619.txt Edgar Link pending
0001104659-22-045619-xbrl.zip Edgar Link pending
dsac-20211231.xsd Edgar Link pending
dsac-20211231x10k.htm Edgar Link pending
dsac-20211231x10k_htm.xml Edgar Link completed
dsac-20211231xex31d1.htm Edgar Link pending
dsac-20211231xex31d2.htm Edgar Link pending
dsac-20211231xex32d1.htm Edgar Link pending
dsac-20211231xex32d2.htm Edgar Link pending
dsac-20211231_cal.xml Edgar Link unprocessable
dsac-20211231_def.xml Edgar Link unprocessable
dsac-20211231_lab.xml Edgar Link unprocessable
dsac-20211231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending